alexa Long-term anticoagulation in patients with coronary disease, and future developments.
Cardiology

Cardiology

Journal of Clinical & Experimental Cardiology

Author(s): Verheugt FW

Abstract Share this page

Abstract PURPOSE OF REVIEW: As anticoagulant therapy is a cornerstone in the early management of acute coronary syndrome, the question remains whether long-term anticoagulation after discharge will further improve outcome. RECENT FINDINGS: Major trials demonstrated benefit from routine oral anticoagulation with an attained international normalized ratio over 2.0 in patients after myocardial infarction. However, the benefit seen in these trials was achieved at the expense of increased bleeding and high dropout rate. In addition, a significant number of patients in both these trials had an international normalized ratio below the target range. Furthermore, the trials were performed before the clopidogrel era in which the great majority of patients with both non-ST-elevation and ST-elevation acute coronary syndromes are treated with an early invasive strategy. The benefit with warfarin therapy is in the range of benefit seen with clopidogrel, which is easier to administer, and there are no data assessing a possible benefit of warfarin therapy in patients taking aspirin and clopidogrel in whom the bleeding risk might be excessive. Very recently, direct oral thrombin blockade has been developed and found to be effective in venous thromboembolism and after myocardial infarction. In addition, oral direct factor Xa blockers are also good candidates for replacing warfarin. SUMMARY: Oral anticoagulation after myocardial infarction is beneficial but increases bleeding risk and is notoriously difficult to monitor. Novel oral anticoagulants are currently evaluated for this indication with aspirin and clopidogrel as background therapy. This article was published in Curr Opin Cardiol and referenced in Journal of Clinical & Experimental Cardiology

Relevant Expert PPTs

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords